BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DEMENTIA RESEARCHER - ECPv6.14.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DEMENTIA RESEARCHER
X-ORIGINAL-URL:https://www.dementiaresearcher.nihr.ac.uk
X-WR-CALDESC:Events for DEMENTIA RESEARCHER
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251209T090000
DTEND;TZID=Europe/London:20251209T173000
DTSTAMP:20260404T043024
CREATED:20251127T193339Z
LAST-MODIFIED:20251127T193339Z
UID:10002004-1765270800-1765301400@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Proteomics: a new era for Biomarkers in Medicine
DESCRIPTION:Join Alamar Biosciences and Spedali Civili di Brescia\, University of Brescia for an intensive\, one‑day translational forum uniting internationally recognised KOLs to examine what’s ready now in proteomic biomarkers and explore how the sensitivity of the NULISA ™ technology is applied to Biomarkers Discovery and Clinical Development. \nDiscover the latest breakthroughs and innovative approaches using NULISA\, an ultra-high sensitivity proteomic platform measuring proteins down to a level of fg/ml in multiplex format. This cutting-edge technology holds the promise of advancing and transforming our understanding\, as well as finding new treatments for different disease conditions. \n\n09:00 – 09:15 | OPENING SESSION\n\n\n\n\n\n09:00 – 09:15 | Welcome and Opening\, Alessandro Padovani & Andrea Pilotto\, University of Brescia\, ASST Spedli Civili of Brescia\n\n09:15 – 11:30 | SESSION ONE | Biomarker discovery\n\n\n\n\n09:15 – 10:00 | NULISA™ and its use in fluid biomarker discovery\, Michael Evans & Mathias Holpert\, Alamar Biosciences\n10:00 – 10:30 | Proteomic profiling in Multiple Sclerosis\, Jens Kuhle\, Basel Hospital\, Switzerland (Virtual)\n10:30 – 11:00 | Biomarkers discovery across neurodegenerative conditions\, Andrea Benedet\, University of Gothenburg\, Sweden\n11:00 – 11:30 | Coffee Break\n\n11:30 – 13:45 | SESSION TWO | Animal models and new protein targets\n\n\n\n\n11:30 – 12:00 | Mouse models in TBI and Neurodegeneration\, Federico Moro\, Mario Negri Milan\, Italy\n12:00 – 12:30 | Proteomic profiles as new target in ALS\, Alberto Catanese\, University of Freiburg\, Germany (Virtual)\n12:30 – 13:00 | Inflammatory profiles in central and peripheral conditions\, Matteo Gastaldi\, University of Pavia\, Italy\n13:00 – 13:45 | Lunch & Networking\n\n13:45 – 16:00 | SESSION THREE | Brain health beyond\n\n\n\n\n13:45 – 14:10 | Biomarkers of Brain Health in at-risk individuals\, Paula Ortiz-Romero\, BarcelonaBeta Brain Research Center\, Spain\n14:10 – 14:35 | Biomarkers of Brain health in general aging population\, Giulia Grande\, Karolinska Institute\, Sweden\n14:35 – 15:00 | Proteomics profiling in type 2 diabetes and obesity\, Prof. Edoardo Mannucci\, University of Florence\, Italy\n15:00 – 15:30 | Biological and molecular basis of Major Psychiatric disorders: overview and future perspectives\, Prof Antonio Rampino\, University of Bari\, Italy\n15:30 – 16:00 | Coffee Break\n\n16:00 – 16:40 | SESSION FOUR | Key lecture\n\n\n\n\n16:00 – 16:40 | Proteomic biomarkers discovery: challenges\, opportunities and future scenarios\, Nick Ashton\, Bannerhealth\, U.S.A (Virtual)\n\n16:45 – 17:45 | SESSION FIVE | Ongoing projects & Closing\n\n\n\n\n16:45 – 17:30 | Flash communication and ongoing projects\n17:30 – 17:45 | Closing remarks followed by networking reception\n\n\nRegister to Attend
URL:https://www.dementiaresearcher.nihr.ac.uk/event/proteomics-a-new-era-for-biomarkers-in-medicine/
LOCATION:Online\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2025/09/Alamar-Biosciences-virtual-ARGOnaut-Club-Voyager-Summit-2025.png
END:VEVENT
END:VCALENDAR